Timothy Daley
Stock Analyst at Wells Fargo
(2.58)
# 2,176
Out of 4,876 analysts
58
Total ratings
54.29%
Success rate
1.11%
Average return
Main Sectors:
Stocks Rated by Timothy Daley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QGEN Qiagen | Initiates: Equal-Weight | $47 | $47.77 | -2.28% | 1 | Dec 19, 2023 | |
| MYGN Myriad Genetics | Initiates: Equal-Weight | $20 | $5.25 | +280.95% | 1 | Dec 19, 2023 | |
| RVTY Revvity | Initiates: Equal-Weight | $95 | $97.82 | -2.88% | 1 | Dec 19, 2023 | |
| BRKR Bruker | Initiates: Equal-Weight | $72 | $41.80 | +72.25% | 1 | Dec 19, 2023 | |
| A Agilent Technologies | Maintains: Overweight | $160 → $145 | $119.17 | +21.67% | 5 | Nov 22, 2023 | |
| MTD Mettler-Toledo International | Maintains: Overweight | $1,520 → $1,300 | $1,184.54 | +9.75% | 5 | Nov 13, 2023 | |
| WAT Waters | Maintains: Equal-Weight | $305 → $285 | $352.41 | -19.13% | 5 | Nov 8, 2023 | |
| DHR Danaher | Maintains: Overweight | $285 → $247 | $198.80 | +24.25% | 3 | Oct 3, 2023 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $280 → $275 | $150.01 | +83.32% | 4 | Sep 22, 2023 | |
| LH Labcorp Holdings | Maintains: Overweight | $290 → $270 | $260.59 | +3.61% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $22 → $28 | $4.73 | +491.97% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $35 | $24.64 | +42.05% | 6 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $505 → $520 | $408.28 | +27.36% | 3 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $9 | $1.70 | +429.41% | 1 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $185 | $123.56 | +49.72% | 1 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $80 → $85 | $65.01 | +30.75% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $235 → $220 | $157.47 | +39.71% | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $245 → $220 | $144.56 | +52.19% | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 → $28 | $13.53 | +106.95% | 4 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $135 → $140 | $177.83 | -21.27% | 2 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $90 | $51.84 | +73.61% | 3 | Jan 10, 2023 |
Qiagen
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $47
Current: $47.77
Upside: -2.28%
Myriad Genetics
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $20
Current: $5.25
Upside: +280.95%
Revvity
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $95
Current: $97.82
Upside: -2.88%
Bruker
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $72
Current: $41.80
Upside: +72.25%
Agilent Technologies
Nov 22, 2023
Maintains: Overweight
Price Target: $160 → $145
Current: $119.17
Upside: +21.67%
Mettler-Toledo International
Nov 13, 2023
Maintains: Overweight
Price Target: $1,520 → $1,300
Current: $1,184.54
Upside: +9.75%
Waters
Nov 8, 2023
Maintains: Equal-Weight
Price Target: $305 → $285
Current: $352.41
Upside: -19.13%
Danaher
Oct 3, 2023
Maintains: Overweight
Price Target: $285 → $247
Current: $198.80
Upside: +24.25%
Charles River Laboratories International
Sep 22, 2023
Maintains: Overweight
Price Target: $280 → $275
Current: $150.01
Upside: +83.32%
Labcorp Holdings
Aug 14, 2023
Maintains: Overweight
Price Target: $290 → $270
Current: $260.59
Upside: +3.61%
Aug 14, 2023
Maintains: Overweight
Price Target: $22 → $28
Current: $4.73
Upside: +491.97%
Jul 31, 2023
Maintains: Overweight
Price Target: $30 → $35
Current: $24.64
Upside: +42.05%
Jul 28, 2023
Maintains: Underweight
Price Target: $505 → $520
Current: $408.28
Upside: +27.36%
Jul 20, 2023
Initiates: Overweight
Price Target: $9
Current: $1.70
Upside: +429.41%
Jul 20, 2023
Initiates: Overweight
Price Target: $185
Current: $123.56
Upside: +49.72%
May 2, 2023
Maintains: Equal-Weight
Price Target: $80 → $85
Current: $65.01
Upside: +30.75%
May 1, 2023
Maintains: Equal-Weight
Price Target: $235 → $220
Current: $157.47
Upside: +39.71%
May 1, 2023
Maintains: Equal-Weight
Price Target: $245 → $220
Current: $144.56
Upside: +52.19%
Feb 8, 2023
Maintains: Overweight
Price Target: $25 → $28
Current: $13.53
Upside: +106.95%
Feb 3, 2023
Maintains: Equal-Weight
Price Target: $135 → $140
Current: $177.83
Upside: -21.27%
Jan 10, 2023
Upgrades: Equal-Weight
Price Target: $90
Current: $51.84
Upside: +73.61%